Dana-Farber Cancer Institute and Boston Children's Hospital — Boston, Massachusetts

Dana-Farber Cancer Institute and Boston Children's Hospital is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute and Boston Children's Hospital has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent.

Sponsors: Medical University of Vienna.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute and Boston Children's Hospital?

Dana-Farber Cancer Institute and Boston Children's Hospital has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute and Boston Children's Hospital conducted?

Dana-Farber Cancer Institute and Boston Children's Hospital has 1 clinical trials on record, with 1 currently active. Their work covers Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent.

Is Dana-Farber Cancer Institute and Boston Children's Hospital accredited by Crixeo Health?

Dana-Farber Cancer Institute and Boston Children's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Institute and Boston Children's Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.